Zolgensma was a one-time treatment for spinal muscular atrophy, a disease that affects about 1 in 10,000 births and which results in death or the need for permanent ventilation by the age of two in 90 percent of cases.
from Hindustan Times - world http://bit.ly/2HA4gTO
Post Top Ad
Responsive Ads Here
Sunday, May 26, 2019
US approves world's costliest drug to treat rare childhood disorder
Tags
# Hindustan Times - world
Share This
About MAHENDRA KUMAR
Hindustan Times - world
Labels:
Hindustan Times - world
Subscribe to:
Post Comments (Atom)
Post Bottom Ad
Responsive Ads Here
No comments:
Post a Comment